Hematopoietic stem cell transplantation positively affects the natural history of cancer in Nijmegen breakage syndrome

Purpose: Nijmegen breakage syndrome (NBS) is a DNA repair disorder with a high predisposition to hematologic malignancies. - Experimental Design: We describe the natural history of NBS, including cancer incidence, risk of death, and the potential effectiveness of hematopoietic stem cell transplantat...

Full description

Saved in:
Bibliographic Details
Main Authors: Wolska-Kusnierz, Beata (Author) , Greil, Johann (Author)
Format: Article (Journal)
Language:English
Published: 2021
In: Clinical cancer research
Year: 2020, Volume: 27, Issue: 2, Pages: 575-584
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-20-2574
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1158/1078-0432.CCR-20-2574
Verlag, lizenzpflichtig, Volltext: https://clincancerres.aacrjournals.org/content/27/2/575
Get full text
Author Notes:Beata Wolska-Kusnierz, Agata Pastorczak, Wojciech Fendler, Anna Wakulinska, Bozena Dembowska-Baginska, Edyta Heropolitanska-Pliszka, Barbara Piątosa, Barbara Pietrucha, Krzysztof Kałwak, Marek Ussowicz, Anna Pieczonka, Katarzyna Drabko, Monika Lejman, Sylwia Koltan, Jolanta Gozdzik, Jan Styczynski, Alina Fedorova, Natalia Miakova, Elena Deripapa, Larysa Kostyuchenko, Zdenka Krenova, Eva Hlavackova, Andrew R. Gennery, Karl-Walter Sykora, Sujal Ghosh, Michael H. Albert, Dmitry Balashov, Mary Eapen, Peter Svec, Markus G. Seidel, Sara S. Kilic, Agnieszka Tomaszewska, Ewa Wiesik-Szewczyk, Alexandra Kreins, Johann Greil, Jochen Buechner, Bendik Lund, Hanna Gregorek, Krystyna Chrzanowska, and Wojciech Mlynarski

MARC

LEADER 00000caa a2200000 c 4500
001 1753979692
003 DE-627
005 20220819162641.0
007 cr uuu---uuuuu
008 210413r20212020xx |||||o 00| ||eng c
024 7 |a 10.1158/1078-0432.CCR-20-2574  |2 doi 
035 |a (DE-627)1753979692 
035 |a (DE-599)KXP1753979692 
035 |a (OCoLC)1341404100 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Wolska-Kusnierz, Beata  |e VerfasserIn  |0 (DE-588)1231310073  |0 (DE-627)1753981697  |4 aut 
245 1 0 |a Hematopoietic stem cell transplantation positively affects the natural history of cancer in Nijmegen breakage syndrome  |c Beata Wolska-Kusnierz, Agata Pastorczak, Wojciech Fendler, Anna Wakulinska, Bozena Dembowska-Baginska, Edyta Heropolitanska-Pliszka, Barbara Piątosa, Barbara Pietrucha, Krzysztof Kałwak, Marek Ussowicz, Anna Pieczonka, Katarzyna Drabko, Monika Lejman, Sylwia Koltan, Jolanta Gozdzik, Jan Styczynski, Alina Fedorova, Natalia Miakova, Elena Deripapa, Larysa Kostyuchenko, Zdenka Krenova, Eva Hlavackova, Andrew R. Gennery, Karl-Walter Sykora, Sujal Ghosh, Michael H. Albert, Dmitry Balashov, Mary Eapen, Peter Svec, Markus G. Seidel, Sara S. Kilic, Agnieszka Tomaszewska, Ewa Wiesik-Szewczyk, Alexandra Kreins, Johann Greil, Jochen Buechner, Bendik Lund, Hanna Gregorek, Krystyna Chrzanowska, and Wojciech Mlynarski 
264 1 |c 2021 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published OnlineFirst October 20, 2020 
500 |a Gesehen am 13.04.2021 
520 |a Purpose: Nijmegen breakage syndrome (NBS) is a DNA repair disorder with a high predisposition to hematologic malignancies. - Experimental Design: We describe the natural history of NBS, including cancer incidence, risk of death, and the potential effectiveness of hematopoietic stem cell transplantation (HSCT) in preventing both pathologies: malignancy and immunodeficiency. - Results: Among 241 patients with NBS enrolled in the study from 11 countries, 151 (63.0%) patients were diagnosed with cancer. Incidence rates for primary and secondary cancer, tumor characteristics, and risk factors affecting overall survival (OS) were estimated. The cumulative cancer incidence was 40.21% ± 3.5% and 77.78% ± 3.4% at 10 years and 20 years of follow-up, respectively. Most of the tumors n = 95 (62.9%) were non-Hodgkin lymphomas. Overall, 20 (13.2%) secondary malignancies occurred at a median age of 18 (interquartile range, 13.7-21.5) years. The probability of 20-year overall survival (OS) for the whole cohort was 44.6% ± 4.5%. Patients who developed cancer had a shorter 20-year OS than those without malignancy (29.6% vs. 86.2%; P < 10−5). A total of 49 patients with NBS underwent HSCT, including 14 patients transplanted before malignancy. Patients with NBS with diagnosed cancer who received HSCT had higher 20-year OS than those who did not (42.7% vs. 30.3%; P = 0.038, respectively). In the group of patients who underwent preemptive transplantation, only 1 patient developed cancer, which is 6.7 times lower as compared with nontransplanted patients [incidence rate ratio 0.149 (95% confidence interval, 0.138-0.162); P < 0.0001]. - Conclusions: There is a beneficial effect of HSCT on the long-term survival of patients with NBS transplanted in their first complete remission of cancer. 
534 |c 2020 
700 1 |a Greil, Johann  |e VerfasserIn  |0 (DE-588)1078331979  |0 (DE-627)838332455  |0 (DE-576)450711498  |4 aut 
773 0 8 |i Enthalten in  |t Clinical cancer research  |d Philadelphia, Pa. [u.a.] : AACR, 1995  |g 27(2021), 2, Seite 575-584  |h Online-Ressource  |w (DE-627)325489971  |w (DE-600)2036787-9  |w (DE-576)094502234  |x 1557-3265  |7 nnas  |a Hematopoietic stem cell transplantation positively affects the natural history of cancer in Nijmegen breakage syndrome 
773 1 8 |g volume:27  |g year:2021  |g number:2  |g pages:575-584  |g extent:10  |a Hematopoietic stem cell transplantation positively affects the natural history of cancer in Nijmegen breakage syndrome 
856 4 0 |u https://doi.org/10.1158/1078-0432.CCR-20-2574  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://clincancerres.aacrjournals.org/content/27/2/575  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210413 
993 |a Article 
994 |a 2021 
998 |g 1078331979  |a Greil, Johann  |m 1078331979:Greil, Johann  |d 910000  |d 910500  |d 50000  |e 910000PG1078331979  |e 910500PG1078331979  |e 50000PG1078331979  |k 0/910000/  |k 1/910000/910500/  |k 0/50000/  |p 35 
999 |a KXP-PPN1753979692  |e 390683381X 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"Hematopoietic stem cell transplantation positively affects the natural history of cancer in Nijmegen breakage syndrome","title":"Hematopoietic stem cell transplantation positively affects the natural history of cancer in Nijmegen breakage syndrome"}],"person":[{"given":"Beata","family":"Wolska-Kusnierz","role":"aut","roleDisplay":"VerfasserIn","display":"Wolska-Kusnierz, Beata"},{"display":"Greil, Johann","roleDisplay":"VerfasserIn","role":"aut","family":"Greil","given":"Johann"}],"note":["Published OnlineFirst October 20, 2020","Gesehen am 13.04.2021"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1753979692","language":["eng"],"origin":[{"dateIssuedDisp":"2021","dateIssuedKey":"2021"}],"id":{"eki":["1753979692"],"doi":["10.1158/1078-0432.CCR-20-2574"]},"name":{"displayForm":["Beata Wolska-Kusnierz, Agata Pastorczak, Wojciech Fendler, Anna Wakulinska, Bozena Dembowska-Baginska, Edyta Heropolitanska-Pliszka, Barbara Piątosa, Barbara Pietrucha, Krzysztof Kałwak, Marek Ussowicz, Anna Pieczonka, Katarzyna Drabko, Monika Lejman, Sylwia Koltan, Jolanta Gozdzik, Jan Styczynski, Alina Fedorova, Natalia Miakova, Elena Deripapa, Larysa Kostyuchenko, Zdenka Krenova, Eva Hlavackova, Andrew R. Gennery, Karl-Walter Sykora, Sujal Ghosh, Michael H. Albert, Dmitry Balashov, Mary Eapen, Peter Svec, Markus G. Seidel, Sara S. Kilic, Agnieszka Tomaszewska, Ewa Wiesik-Szewczyk, Alexandra Kreins, Johann Greil, Jochen Buechner, Bendik Lund, Hanna Gregorek, Krystyna Chrzanowska, and Wojciech Mlynarski"]},"physDesc":[{"extent":"10 S."}],"relHost":[{"language":["eng"],"corporate":[{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"American Association for Cancer Research"}],"recId":"325489971","disp":"Hematopoietic stem cell transplantation positively affects the natural history of cancer in Nijmegen breakage syndromeClinical cancer research","note":["Gesehen am 08.06.2023","Fortsetzung der Druck-Ausgabe"],"type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"volume":"27","text":"27(2021), 2, Seite 575-584","extent":"10","year":"2021","issue":"2","pages":"575-584"},"pubHistory":["1.1995 -"],"title":[{"title_sort":"Clinical cancer research","title":"Clinical cancer research"}],"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["American Association for Cancer Research"]},"id":{"issn":["1557-3265"],"eki":["325489971"],"zdb":["2036787-9"]},"origin":[{"publisherPlace":"Philadelphia, Pa. [u.a.]","dateIssuedDisp":"1995-","publisher":"AACR","dateIssuedKey":"1995"}]}]} 
SRT |a WOLSKAKUSNHEMATOPOIE2021